CAS 1093746-29-2

Montelukast-d6

CAS : 1093746-29-2

Formule : C₃₅H₃₀D₆ClNO₃S

Couleur et forme : Yellow Solid

Masse moléculaire : 592.22

Ref: 4Z-M-305

Montelukast Impurity 32

CAS : 1093746-29-2, 158966-92-8

Formule : C₂₉H₂₆ClNO

Masse moléculaire : 439.98

Ref: 4Z-M-3059

Montelukast-d6 Sodium Salt

Produit contrôlé

CAS : 1093746-29-2, 151767-02-1, 158966-92-8

Formule : C₃₅H₂₉D₆ClNNaO₃S

Couleur et forme : Neat

Masse moléculaire : 614.2

Ref: TR-M568002

Montelukast-d6

CAS : 1093746-29-2

Montelukast-d6 is an analog of Montelukast, a drug used for the treatment of asthma and allergic rhinitis. Montelukast-d6 has been shown to have anticancer properties by inhibiting the activity of certain kinases that are involved in cancer cell growth and proliferation. This drug has been found to induce apoptosis in human cancer cells, making it a promising candidate for cancer therapy. Montelukast-d6 is also a potent inhibitor of protein kinases, which play a key role in tumor development and progression. This inhibitor has been shown to inhibit the growth of tumors in mice, suggesting its potential as an effective anticancer agent. Montelukast-d6 can be detected in urine samples using liquid chromatography-tandem mass spectrometry (LC-MS/MS) techniques, making it useful for monitoring drug levels during clinical trials or treatment.

Formule : C₃₅H₃₆ClNO₃S

Degré de pureté : Min. 95%

Masse moléculaire : 592.2 g/mol

Ref: 3D-TTB74629